世界のがん診断市場2023-2027

【英語タイトル】Global Cancer Diagnostics Market

Technavioが出版した調査資料(IRTNTR75667-23)・商品コード:IRTNTR75667-23
・発行会社(調査会社):Technavio
・発行日:2023年6月
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

がん診断の世界市場 2023-2027
がん診断市場は2022-2027年に12,626.21百万ドルで成長し、予測期間中のCAGRは11.3%で加速すると予測されています。当レポートでは、がん診断市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25の企業を網羅した企業分析を掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がんの高い有病率、個別化医薬品の需要、創薬・開発におけるコスト削減の必要性によって牽引されています。

Technavioのがん診断市場は以下のように区分されます:

エンドユーザー別
- 病院&診療所
- 診断研究所

タイプ別
- 体外診断用医薬品
- 画像診断
- LDT

地域別
- 北米
- ヨーロッパ
- APAC
- その他の地域(ROW)

本調査では、今後数年間におけるがん診断市場の成長を促進する主な要因の一つとして、研究開発の増加と技術の進歩を挙げています。また、ライセンス契約や製品の商品化といった様々な戦略の採用や、人口が多い新興国に注力してプレゼンスを拡大する企業も、市場の大きな需要につながるでしょう。

本レポートでは、がん診断市場について以下の領域をカバーしています:
- がん診断市場のサイジング
- がん診断市場予測
- がん診断市場の産業分析

堅牢な企業分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って、本レポートでは、Abbott Laboratories、Agilent Technologies Inc.、Astellas Pharma Inc.、Becton Dickinson and Co、 bioMerieux SA、Bristol Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、General Electric Co.、GlaxoSmithKline Plc、Hologic Inc.、Illumina Inc.、Merck KGaA、Myriad Genetics Inc.、Novartis AG、Pfizer Inc.、QIAGEN NV、Quest Diagnostics Inc.、Siemens AG、Thermo Fisher Scientific Inc.を含むいくつかの主要ながん診断市場企業の詳細な分析を掲載しています。等また、がん診断市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場および企業状況が含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密な企業選定方法と分析を掲載しています。

1. エグゼクティブサマリー
2. 市場概況
3. 市場規模
4. 過去の市場規模
5. ファイブフォース分析
6. がん診断の世界市場:エンドユーザー別
7. がん診断の世界市場:種類別
8. 顧客状況
9. 地域別状況
10. 推進要因・課題・動向
11. 企業状況
12. 企業分析
13. 付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cancer diagnostics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global cancer diagnostics market 2017 – 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals and clinics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o 6.4 Diagnostic laboratories – Market size and forecast 2022-2027
o Exhibit 38: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by End-user
o Exhibit 42: Market opportunity by End-user ($ million)
o Exhibit 43: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 IVD – Market size and forecast 2022-2027
o Exhibit 48: Chart on IVD – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on IVD – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on IVD – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on IVD – Year-over-year growth 2022-2027 (%)
o 7.4 Imaging – Market size and forecast 2022-2027
o Exhibit 52: Chart on Imaging – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Imaging – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Imaging – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Imaging – Year-over-year growth 2022-2027 (%)
o 7.5 LDT – Market size and forecast 2022-2027
o Exhibit 56: Chart on LDT – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on LDT – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on LDT – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on LDT – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Type
o Exhibit 60: Market opportunity by Type ($ million)
o Exhibit 61: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 APAC – Market size and forecast 2022-2027
o Exhibit 75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on APAC – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 99: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories – Overview
o Exhibit 112: Abbott Laboratories – Business segments
o Exhibit 113: Abbott Laboratories – Key news
o Exhibit 114: Abbott Laboratories – Key offerings
o Exhibit 115: Abbott Laboratories – Segment focus
o 12.4 Agilent Technologies Inc.
o Exhibit 116: Agilent Technologies Inc. – Overview
o Exhibit 117: Agilent Technologies Inc. – Business segments
o Exhibit 118: Agilent Technologies Inc. – Key offerings
o Exhibit 119: Agilent Technologies Inc. – Segment focus
o 12.5 Becton Dickinson and Co.
o Exhibit 120: Becton Dickinson and Co. – Overview
o Exhibit 121: Becton Dickinson and Co. – Business segments
o Exhibit 122: Becton Dickinson and Co. – Key news
o Exhibit 123: Becton Dickinson and Co. – Key offerings
o Exhibit 124: Becton Dickinson and Co. – Segment focus
o 12.6 Bristol Myers Squibb Co.
o Exhibit 125: Bristol Myers Squibb Co. – Overview
o Exhibit 126: Bristol Myers Squibb Co. – Product / Service
o Exhibit 127: Bristol Myers Squibb Co. – Key news
o Exhibit 128: Bristol Myers Squibb Co. – Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 129: Eli Lilly and Co. – Overview
o Exhibit 130: Eli Lilly and Co. – Product / Service
o Exhibit 131: Eli Lilly and Co. – Key news
o Exhibit 132: Eli Lilly and Co. – Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 General Electric Co.
o Exhibit 138: General Electric Co. – Overview
o Exhibit 139: General Electric Co. – Business segments
o Exhibit 140: General Electric Co. – Key news
o Exhibit 141: General Electric Co. – Key offerings
o Exhibit 142: General Electric Co. – Segment focus
o 12.10 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc – Overview
o Exhibit 144: GlaxoSmithKline Plc – Business segments
o Exhibit 145: GlaxoSmithKline Plc – Key news
o Exhibit 146: GlaxoSmithKline Plc – Key offerings
o Exhibit 147: GlaxoSmithKline Plc – Segment focus
o 12.11 Hologic Inc.
o Exhibit 148: Hologic Inc. – Overview
o Exhibit 149: Hologic Inc. – Business segments
o Exhibit 150: Hologic Inc. – Key news
o Exhibit 151: Hologic Inc. – Key offerings
o Exhibit 152: Hologic Inc. – Segment focus
o 12.12 Illumina Inc.
o Exhibit 153: Illumina Inc. – Overview
o Exhibit 154: Illumina Inc. – Business segments
o Exhibit 155: Illumina Inc. – Key news
o Exhibit 156: Illumina Inc. – Key offerings
o Exhibit 157: Illumina Inc. – Segment focus
o 12.13 Merck KGaA
o Exhibit 158: Merck KGaA – Overview
o Exhibit 159: Merck KGaA – Business segments
o Exhibit 160: Merck KGaA – Key news
o Exhibit 161: Merck KGaA – Key offerings
o Exhibit 162: Merck KGaA – Segment focus
o 12.14 Novartis AG
o Exhibit 163: Novartis AG – Overview
o Exhibit 164: Novartis AG – Business segments
o Exhibit 165: Novartis AG – Key offerings
o Exhibit 166: Novartis AG – Segment focus
o 12.15 QIAGEN NV
o Exhibit 167: QIAGEN NV – Overview
o Exhibit 168: QIAGEN NV – Product / Service
o Exhibit 169: QIAGEN NV – Key news
o Exhibit 170: QIAGEN NV – Key offerings
o 12.16 Quest Diagnostics Inc.
o Exhibit 171: Quest Diagnostics Inc. – Overview
o Exhibit 172: Quest Diagnostics Inc. – Business segments
o Exhibit 173: Quest Diagnostics Inc. – Key offerings
o Exhibit 174: Quest Diagnostics Inc. – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 175: Thermo Fisher Scientific Inc. – Overview
o Exhibit 176: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 177: Thermo Fisher Scientific Inc. – Key news
o Exhibit 178: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 179: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 180: Inclusions checklist
o Exhibit 181: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 182: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 183: Research methodology
o Exhibit 184: Validation techniques employed for market sizing
o Exhibit 185: Information sources
o 13.5 List of abbreviations
o Exhibit 186: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global cancer diagnostics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by End-user ($ million)
Exhibits43: Data Table on Market opportunity by End-user ($ million)
Exhibits44: Chart on Type – Market share 2022-2027 (%)
Exhibits45: Data Table on Type – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on IVD – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on IVD – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on IVD – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on IVD – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Imaging – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Imaging – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Imaging – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Imaging – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on LDT – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on LDT – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on LDT – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on LDT – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Type ($ million)
Exhibits61: Data Table on Market opportunity by Type ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on APAC – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories – Overview
Exhibits112: Abbott Laboratories – Business segments
Exhibits113: Abbott Laboratories – Key news
Exhibits114: Abbott Laboratories – Key offerings
Exhibits115: Abbott Laboratories – Segment focus
Exhibits116: Agilent Technologies Inc. – Overview
Exhibits117: Agilent Technologies Inc. – Business segments
Exhibits118: Agilent Technologies Inc. – Key offerings
Exhibits119: Agilent Technologies Inc. – Segment focus
Exhibits120: Becton Dickinson and Co. – Overview
Exhibits121: Becton Dickinson and Co. – Business segments
Exhibits122: Becton Dickinson and Co. – Key news
Exhibits123: Becton Dickinson and Co. – Key offerings
Exhibits124: Becton Dickinson and Co. – Segment focus
Exhibits125: Bristol Myers Squibb Co. – Overview
Exhibits126: Bristol Myers Squibb Co. – Product / Service
Exhibits127: Bristol Myers Squibb Co. – Key news
Exhibits128: Bristol Myers Squibb Co. – Key offerings
Exhibits129: Eli Lilly and Co. – Overview
Exhibits130: Eli Lilly and Co. – Product / Service
Exhibits131: Eli Lilly and Co. – Key news
Exhibits132: Eli Lilly and Co. – Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. – Overview
Exhibits134: F. Hoffmann La Roche Ltd. – Business segments
Exhibits135: F. Hoffmann La Roche Ltd. – Key news
Exhibits136: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits138: General Electric Co. – Overview
Exhibits139: General Electric Co. – Business segments
Exhibits140: General Electric Co. – Key news
Exhibits141: General Electric Co. – Key offerings
Exhibits142: General Electric Co. – Segment focus
Exhibits143: GlaxoSmithKline Plc – Overview
Exhibits144: GlaxoSmithKline Plc – Business segments
Exhibits145: GlaxoSmithKline Plc – Key news
Exhibits146: GlaxoSmithKline Plc – Key offerings
Exhibits147: GlaxoSmithKline Plc – Segment focus
Exhibits148: Hologic Inc. – Overview
Exhibits149: Hologic Inc. – Business segments
Exhibits150: Hologic Inc. – Key news
Exhibits151: Hologic Inc. – Key offerings
Exhibits152: Hologic Inc. – Segment focus
Exhibits153: Illumina Inc. – Overview
Exhibits154: Illumina Inc. – Business segments
Exhibits155: Illumina Inc. – Key news
Exhibits156: Illumina Inc. – Key offerings
Exhibits157: Illumina Inc. – Segment focus
Exhibits158: Merck KGaA – Overview
Exhibits159: Merck KGaA – Business segments
Exhibits160: Merck KGaA – Key news
Exhibits161: Merck KGaA – Key offerings
Exhibits162: Merck KGaA – Segment focus
Exhibits163: Novartis AG – Overview
Exhibits164: Novartis AG – Business segments
Exhibits165: Novartis AG – Key offerings
Exhibits166: Novartis AG – Segment focus
Exhibits167: QIAGEN NV – Overview
Exhibits168: QIAGEN NV – Product / Service
Exhibits169: QIAGEN NV – Key news
Exhibits170: QIAGEN NV – Key offerings
Exhibits171: Quest Diagnostics Inc. – Overview
Exhibits172: Quest Diagnostics Inc. – Business segments
Exhibits173: Quest Diagnostics Inc. – Key offerings
Exhibits174: Quest Diagnostics Inc. – Segment focus
Exhibits175: Thermo Fisher Scientific Inc. – Overview
Exhibits176: Thermo Fisher Scientific Inc. – Business segments
Exhibits177: Thermo Fisher Scientific Inc. – Key news
Exhibits178: Thermo Fisher Scientific Inc. – Key offerings
Exhibits179: Thermo Fisher Scientific Inc. – Segment focus
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations



★調査レポート[世界のがん診断市場2023-2027] (コード:IRTNTR75667-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん診断市場2023-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆